Sunridge International to Present PNT to the Southern California Investment Association

Wednesday, March 17, 2010 Corporate News J E 4

FOUNTAIN HILLS, Ariz., March 16 Sunridge International, (OTC Bulletin Board: SNDZ) said it will be presenting details of its patented pneumatic trabeculoplasty treatment (PNT) a non-invasive treatment at the upcoming Southern California Investment Association (SCIA) Conference on April 3rd 2010, in Irvine, CA.

Making the announcement today, Sunridge International CEO, G. Richard Smith, said, "Last Saturday's conference in Texas allowed us to communicate the progress that Sunridge has made in recent months and the inroads it has made in several of the world's major markets. We have had great success in gaining awareness throughout the US investment community in the past month, and our upcoming presentation to the SCIA is an important step in continuing our marketing outreach program."

The SCIA National Small Cap Syndicate is a comprehensive national organization developed to facilitate stock support and capital formation for small and emerging-growth companies. The alliance consists of almost 200 influential member firms plus associates including broker/dealers, investment bankers, investment advisors, analysts, market makers, venture capitalists, fund managers, media and accredited investors. The SCIA syndicate has been instrumental in funding over $100 million per year since 2000 and has introduced many of the good companies available in the markets.

Glaucoma is the second leading cause of blindness, affecting over 70 million people worldwide. PNT has been proven (through studies completed over the last 10 yrs) to be a safe, effective, non-invasive and a cost effective alternative for treatment for glaucoma and ocular hypertension. The 2-minute treatment has been developed, patented, and distributed by Sunridge International, wholly owned subsidiary, Ophthalmic International (

For full details of PNT and its application, we invite you to visit Sunridge International's website at

CONTACT: Jeff Smith, Sunridge International T: +1-480-837-6165 e-mail: website: MEDIA: Victor Webb, Marston Webb International T: (212) 684-6601 e-mail:

SOURCE Sunridge International


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
TruTag Authentication Technology Wins Pharmaceutic...
CardioGenics Announces Lock-Up Agreement with Dr. ...